idh-specific vaccine for high-grade gliomas
Published 6 years ago • 1.9K plays • Length 4:46Download video MP4
Download video MP3
Similar videos
-
1:46
anti-idh 1 vaccine among patients with low-grade glioma
-
3:39
gapvac-101: personalized vaccines for newly-diagnosed glioblastoma
-
1:21
addressing treatment options for idh-mutant gliomas
-
4:41
idh inhibitors in idh mutant low grade and high grade gliomas: a review of current data
-
11:46
current status of vaccines and immunotherapy in high grade gliomas: an update from sno 2016
-
2:28
targeted therapy for idh1 mutant low-grade glioma
-
3:39
vxm01 vaccine in progressive glioblastoma: final results
-
18:21
new treatment for idh mt gliomas
-
6:08
updated results of vorasidenib for idh1/2 mutant glioma
-
11:10
targeting idh mutations in glioma: implications of new data
-
38:40
brcaness in malignant gliomas: missing the idh1 story - john m. henson, m d, mba
-
37:51
implications of rapid idh1/idh2 testing for liquid and solid tumors
-
2:46
the rapid progression of idh1/2 mutant enzyme inhibitors through clinical trials
-
1:14
the impact of idh mutations in mds & evaluating the role of idh inhibitors
-
2:23
vorasidenib in idh-mutant glioma | nejm
-
2:08
the impact of idh mutations on the outcomes of patients with aml & inhibitors under investigation
-
1:53
treatment strategies for patients with idh1/2-mutated aml ineligible for intensive chemotherapy
-
2:37
improving glioma surgery using a real time fluorescence biomarker
-
6:53
ivosidenib for advanced idh1-mutated cca